The two companies, two of the oldest providers of 3D printing products, unveiled their latest partnership at RSNA 2018, which is taking place between November 25 – November 30 in Chicago, IL. By working together, Stratasys and Materialise are hoping to deliver a versatile method of 3D printing patient-specific medical models at the point of care, helping doctors to diagnose and treat patients to the best of their ability.
The validation of PolyJet technology means the use of Stratasys’ J750, J735 and Objet30 Prime multi-material and multi-colour systems are now approved by Materialise, its Mimics inPrint platform said to have been implemented by 16 of the top 20 U.S. hospitals (per U.S. News & World Report rankings). Mimics inPrint received FDA 510k clearance back in March, having been brought to market two years prior, while Stratasys’ PolyJet technology has also been adopted in the medical sector. The J750 and J735 platforms are adept in the production of complex models requiring multiple textures, and in the combination of hard and soft materials to mimic human tissue. The Objet30 Prime desktop machine, meanwhile, is a more affordable, entry-point option, which can assist with surgical planning, training and education.
“By validating Stratasys’ 3D printing technologies through our certification process, we’re giving doctors and hospitals improved access to high-quality anatomical models for personalised care to patients,” commented Bryan Crutchfield, VP and General Manager of Materialise North America. “The addition of multi-colour and multi-material printers to the list of validated printers is aimed to enable healthcare providers to implement a versatile offering that can support their most complex cases across a wide-range of surgical specialties on a single printer.
“At Materialise, we take a hardware-agnostic approach to software development, offering the flexibility to partner with other leaders in the 3D printing industry like Stratasys, a company committed to addressing requirements of the medical community.”
“Historically, pre-surgical planning relied on 2D imaging requiring physicians to mentally reconstruct the patient anatomy. But 3D printing evolves this approach by putting precise replicas of patient anatomy directly in physician hands,” added Eyal Miller, Head of Healthcare Business Unit, Stratasys. “Now the 3D printer that every hospital needs to power their medical modelling comes with additional options for an FDA-cleared software solution.”